Published in J Clin Invest on September 01, 2015
Molecular Profile of Tumor-Specific CD8+ T Cell Hypofunction in a Transplantable Murine Cancer Model. J Immunol (2016) 0.80
Real-Time Imaging of Resident T Cells in Human Lung and Ovarian Carcinomas Reveals How Different Tumor Microenvironments Control T Lymphocyte Migration. Front Immunol (2015) 0.80
Bispecific antibodies in cancer immunotherapy. Hum Vaccin Immunother (2016) 0.80
Profiling cancer testis antigens in non-small-cell lung cancer. JCI Insight (2016) 0.78
Fibroblasts, an inconspicuous but essential player in colon cancer development and progression. World J Gastroenterol (2016) 0.76
MMP-2 gene polymorphisms are associated with type A aortic dissection and aortic diameters in patients. Medicine (Baltimore) (2016) 0.76
Immunosuppressive Myeloid Cells' Blockade in the Glioma Microenvironment Enhances the Efficacy of Immune-Stimulatory Gene Therapy. Mol Ther (2017) 0.75
Role of Autophagy and Apoptosis in Non-Small-Cell Lung Cancer. Int J Mol Sci (2017) 0.75
The development of bispecific antibodies and their applications in tumor immune escape. Exp Hematol Oncol (2017) 0.75
Mesothelioma response to carbon nanotubes is associated with an early and selective accumulation of immunosuppressive monocytic cells. Part Fibre Toxicol (2016) 0.75
Driving an improved CAR for cancer immunotherapy. J Clin Invest (2016) 0.75
ATR Mutations Promote the Growth of Melanoma Tumors by Modulating the Immune Microenvironment. Cell Rep (2017) 0.75
Antitumor activity of orally administered maitake α-glucan by stimulating antitumor immune response in murine tumor. PLoS One (2017) 0.75
Immature myeloid cells in the tumor microenvironment: Implications for immunotherapy. Clin Immunol (2016) 0.75
A current perspective on applications of macrocyclic-peptide-based high-affinity ligands. Biopolymers (2016) 0.75
Looking beyond the cancer cell for effective drug combinations. Genome Med (2016) 0.75
Tissue-resident memory features are linked to the magnitude of cytotoxic T cell responses in human lung cancer. Nat Immunol (2017) 0.75
Molecular Imaging: A Useful Tool for the Development of Natural Killer Cell-Based Immunotherapies. Front Immunol (2017) 0.75
Association Between Inflammatory Diet Pattern and Risk of Colorectal Carcinoma Subtypes Classified by Immune Responses to Tumor. Gastroenterology (2017) 0.75
Cancer Immunotherapy, Part 2: Efficacy, Safety, and Other Clinical Considerations. P T (2017) 0.75
Cancer Immunotherapy, Part 3: Challenges and Future Trends. P T (2017) 0.75
Cancer Immunotherapy, Part 1: Current Strategies and Agents. P T (2017) 0.75
Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med (2012) 52.99
Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. N Engl J Med (2012) 35.24
Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat Med (2002) 23.42
Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med (2000) 19.81
Enhancement of antitumor immunity by CTLA-4 blockade. Science (1996) 17.94
Nivolumab plus ipilimumab in advanced melanoma. N Engl J Med (2013) 17.53
B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat Med (1999) 16.91
Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science (1995) 16.19
Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science (2011) 15.79
Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity (1995) 14.90
T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia. Sci Transl Med (2011) 12.58
Chimeric antigen receptor-modified T cells for acute lymphoid leukemia. N Engl J Med (2013) 10.63
CTLA-4 can function as a negative regulator of T cell activation. Immunity (1994) 9.80
Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. EMBO J (1992) 8.86
CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J Exp Med (1995) 8.31
CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia. Sci Transl Med (2013) 7.99
Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19. Blood (2010) 7.25
Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15. Nat Med (2003) 6.81
Mechanisms of immune evasion by tumors. Adv Immunol (2006) 5.34
Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T-cell receptors. Proc Natl Acad Sci U S A (1993) 5.23
Neoantigens in cancer immunotherapy. Science (2015) 5.16
A new member of the immunoglobulin superfamily--CTLA-4. Nature (1987) 5.10
Breakthrough of the year 2013. Cancer immunotherapy. Science (2013) 5.05
Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected. J Clin Invest (2015) 1.92
Anti-PD-1/PD-L1 therapy of human cancer: past, present, and future. J Clin Invest (2015) 1.67
Immunity, inflammation, and cancer: an eternal fight between good and evil. J Clin Invest (2015) 1.24
Therapeutic cancer vaccines. J Clin Invest (2015) 1.23
CAR therapy: the CD19 paradigm. J Clin Invest (2015) 1.20
Tumor neoantigens: building a framework for personalized cancer immunotherapy. J Clin Invest (2015) 1.13
Tumor-induced myeloid deviation: when myeloid-derived suppressor cells meet tumor-associated macrophages. J Clin Invest (2015) 1.07
Cytotoxic T lymphocyte antigen-4 and immune checkpoint blockade. J Clin Invest (2015) 0.98
From mice to humans: developments in cancer immunoediting. J Clin Invest (2015) 0.90
Innate immunity against vaccinia virus is mediated by TLR2 and requires TLR-independent production of IFN-beta. Blood (2006) 2.35
Innate immune response to adenoviral vectors is mediated by both Toll-like receptor-dependent and -independent pathways. J Virol (2007) 2.33
The TLR9-MyD88 pathway is critical for adaptive immune responses to adeno-associated virus gene therapy vectors in mice. J Clin Invest (2009) 1.73
Heparan sulfate, an endogenous TLR4 agonist, promotes acute GVHD after allogeneic stem cell transplantation. Blood (2012) 1.71
A critical role for direct TLR2-MyD88 signaling in CD8 T-cell clonal expansion and memory formation following vaccinia viral infection. Blood (2008) 1.69
CD4 T cells are required for CD8 T cell survival during both primary and memory recall responses. J Immunol (2007) 1.50
Intrinsic IL-21 signaling is critical for CD8 T cell survival and memory formation in response to vaccinia viral infection. J Immunol (2011) 1.26
Direct action of type I IFN on NK cells is required for their activation in response to vaccinia viral infection in vivo. J Immunol (2008) 1.26
Toll-like receptor 8-mediated activation of murine plasmacytoid dendritic cells by vaccinia viral DNA. Proc Natl Acad Sci U S A (2010) 1.24
Direct TLR2 signaling is critical for NK cell activation and function in response to vaccinia viral infection. PLoS Pathog (2010) 1.22
Innate immune recognition of viruses and viral vectors. Hum Gene Ther (2009) 1.22
Type I IFN signaling on both B and CD4 T cells is required for protective antibody response to adenovirus. J Immunol (2007) 1.20
A critical role for type I IFN-dependent NK cell activation in innate immune elimination of adenoviral vectors in vivo. Mol Ther (2008) 1.15
STAT1 signaling in CD8 T cells is required for their clonal expansion and memory formation following viral infection in vivo. J Immunol (2008) 1.12
NK cell response to vaccinia virus is regulated by myeloid-derived suppressor cells. J Immunol (2012) 1.11
Natural killer cell responses to viral infection. J Innate Immun (2011) 1.03
Natural killer cell-enriched donor lymphocyte infusions from A 3-6/6 HLA matched family member following nonmyeloablative allogeneic stem cell transplantation. Biol Blood Marrow Transplant (2010) 1.03
Transient gain of effector function by CD8+ T cells undergoing peripheral tolerance to high-dose self-antigen. Eur J Immunol (2004) 0.95
Extent of stimulation controls the formation of memory CD8 T cells. J Immunol (2007) 0.91
Myeloid-derived suppressor cells regulate natural killer cell response to adenovirus-mediated gene transfer. J Virol (2012) 0.90
Feasibility of low-dose interleukin-2 therapy following T-cell-depleted nonmyeloablative allogeneic hematopoietic stem cell transplantation from HLA-matched or -mismatched family member donors. Cancer Invest (2011) 0.89
Protection against autoimmunity in nonlymphopenic hosts by CD4+ CD25+ regulatory T cells is antigen-specific and requires IL-10 and TGF-beta. J Immunol (2005) 0.88
Development of a 4-nitroquinoline-1-oxide model of lymph node metastasis in oral squamous cell carcinoma. Oral Oncol (2012) 0.86
The fate of effector CD8 T cells in vivo is controlled by the duration of antigen stimulation. Immunology (2006) 0.86
NKG2D is required for NK cell activation and function in response to E1-deleted adenovirus. J Immunol (2010) 0.84
Interaction of occupational manganese exposure and alcohol drinking aggravates the increase of liver enzyme concentrations from a cross-sectional study in China. Environ Health (2013) 0.84
The role of natural regulatory T cells in infection. Immunol Res (2011) 0.84
The development and function of memory regulatory T cells after acute viral infections. J Immunol (2012) 0.83
Targeting the TLR9-MyD88 pathway in the regulation of adaptive immune responses. Expert Opin Ther Targets (2010) 0.83
Both NK cell-intrinsic and -extrinsic STAT1 signaling are required for NK cell response against vaccinia virus. J Immunol (2013) 0.82
Determination of beta2-agonists by ion chromatography with direct conductivity detection. J Pharm Biomed Anal (2005) 0.81
Cognitive function and plasma BDNF levels among manganese-exposed smelters. Occup Environ Med (2014) 0.81
In silico syndrome prediction for coronary artery disease in traditional chinese medicine. Evid Based Complement Alternat Med (2012) 0.81
Enantiomeric separation of beta-blockers by HPLC using (R)-1-naphthylglycine and 3,5-dinitrobenzoic acid as chiral stationary phase. J Pharm Biomed Anal (2003) 0.80
Induction of type I IFN is required for overcoming tumor-specific T-cell tolerance after stem cell transplantation. Blood (2009) 0.80
Targeting co-stimulatory pathways in gene therapy. Front Microbiol (2011) 0.80
Immunotherapy of surgical malignancies. Curr Probl Surg (2004) 0.79
NK cell-extrinsic IL-18 signaling is required for efficient NK-cell activation by vaccinia virus. Eur J Immunol (2014) 0.79
Pathway Pattern-based prediction of active drug components and gene targets from H1N1 influenza's treatment with maxingshigan-yinqiaosan formula. Mol Biosyst (2013) 0.79
Heparan sulfate mimetic PG545-mediated antilymphoma effects require TLR9-dependent NK cell activation. J Clin Invest (2015) 0.77
The benefits of restraint: a pivotal role for IL-13 in hepatic glucose homeostasis. J Clin Invest (2012) 0.77
Enhanced separation of purine and pyrimidine bases using carboxylic multiwalled carbon nanotubes as additive in capillary zone electrophoresis. Electrophoresis (2006) 0.76
On the use of dispersed nanoparticles modified with single layer beta-cyclodextrin as chiral selecor to enhance enantioseparation of clenbuterol with capillary electrophoresis. Talanta (2005) 0.75
Driving an improved CAR for cancer immunotherapy. J Clin Invest (2016) 0.75
Chiral separation of four fluoroquinolone compounds using capillary electrophoresis with hydroxypropyl-beta-cyclodextrin as chiral selector. J Chromatogr A (2006) 0.75
PD-L1 serves as a double agent in separating GVL from GVHD. J Clin Invest (2017) 0.75
[Prediction of network drug target based on improved model of bipartite graph valuation]. Zhongguo Zhong Yao Za Zhi (2012) 0.75
[Network-based local and global consistency of cardiovascular genes]. Zhongguo Zhong Yao Za Zhi (2012) 0.75
[The relationship between expression of mitogen-activated protein kinase kinase 4 and metastasis in oral squamous cell carcinoma]. Hua Xi Kou Qiang Yi Xue Za Zhi (2011) 0.75
[Study on chemical constituents from stem of Mallotus apelta]. Zhong Yao Cai (2005) 0.75
Preliminary Epidemiology of Human Infections with Highly Pathogenic Avian Influenza A(H7N9) Virus, China, 2017. Emerg Infect Dis (2017) 0.75
Capillary electrophoretic determination of apoptosis of rat cerebellar granule cells induced by 1-methyl-4-phenyl pyridium ion. Electrophoresis (2002) 0.75